Evidence map›Paper›PMID 34790828›Full record

ArticleJournal of immunology research2021

Lentinan Attenuates Damage of the Small Intestinal Mucosa, Liver, and Lung in Mice with Gut-Origin Sepsis.

Zhongshen Kuang, Tingting Jin, ChangYi Wu, Yanan Zong, Panpan Yin, WangYu Dong, Xue Lin, WeiYan You, Chenlong Zhang, Lijie Wang and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Lentinan progress in inflammatory diseases and tumor diseases.European journal of medical research · 2024
    Review
  8. Article
  9. Review
  10. Anti-Influenza Effect and Mechanisms of Lentinan in an ICR Mouse Model.Frontiers in cellular and infection microbiology · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Zhongshen KuangDepartment of Intensive Care Unit, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang 832002, China.ORCID https://orcid.org/0000-0003-1400-0717
Tingting JinDepartment of Intensive Care Unit, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang 832002, China.
ChangYi WuDepartment of Anesthesiology, Peking University Third Hospital, Beijing 100191, China.
Yanan ZongDepartment of Anesthesiology, Peking University Third Hospital, Beijing 100191, China.
Panpan YinDepartment of Intensive Care Unit, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang 832002, China.
WangYu DongDepartment of Intensive Care Unit, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang 832002, China.
Xue LinDepartment of Intensive Care Unit, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang 832002, China.
WeiYan YouDepartment of Intensive Care Unit, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang 832002, China.
Chenlong ZhangDepartment of Traditional Chinese Medicine, Xiang'an Hospital of Xiamen University, Xiamen, Fujian 361100, China.
Lijie WangDepartment of Intensive Care Unit, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang 832002, China.
Yongying LiuDepartment of Intensive Care Unit, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang 832002, China.
Shan RenDepartment of Intensive Care Unit, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang 832002, China.
Jiangwen YinDepartment of Anesthesiology, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang 832002, China.
Hang XuDepartment of Intensive Care Unit, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang 832002, China.ORCID https://orcid.org/0000-0001-9081-8209
Shihezi University · CNPeking University · CNXiamen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study is aimed at exploring the effects of lentinan on small intestinal mucosa as well as lung and liver injury in mice with gut-origin sepsis. Cecal ligation and perforation (CLP) were used to construct a mouse model of gut-origin sepsis. The mice were randomly divided into six groups: sham operation group (sham), gut-origin sepsis model group (CLP), ulinastatin-positive drug control group (UTI), lentinan low concentration group (LTN-L, 5 mg/kg), lentinan medium concentration group (LTN-M, 10 mg/kg), and lentinan high concentration group (LTN-H, 20 mg/kg). H&E staining was used to detect the pathological damage of the small intestine, liver, and lung. The serum of mice in each group was collected to detect the expression changes of inflammatory cytokines, oxidative stress biomarkers, and liver function indexes. In vitro assessment of bacterial translocation was achieved through inoculated culture media. Western blot and RT-qPCR were used to detect the expression of molecules related to the NF-

Indexed as

AnimalsCytokinesDisease Models, AnimalInflammationInterleukin-10Intestinal MucosaIntestine, SmallLentinanLiverLungMaleMiceNF-kappa BSepsisSignal TransductionCytokinesInterleukin-10LentinanNF-kappa B

Identifiers

PMID34790828
PMCPMC8592742
OpenAlexW3213002415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.